EHPM Co-Founder Michel Horn's Legacy in European Supplement Regulation
Michel Horn, a driving force behind the European Health Product Manufacturers (EHPM), has played a pivotal role in shaping the regulatory landscape for food supplements in Europe. His extensive career highlights the long journey toward formal recognition and harmonisation within the natural health products sector, offering crucial insights for manufacturers and brands alike.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Pioneering Europe's Supplement Landscape: Michel Horn's Enduring Influence
The journey of food supplements from niche products to a recognised category within the vast European food industry owes much to the dedication of long-standing figures within advocacy organisations. One such individual is Michel Horn, co-founder of the European Health Product Manufacturers (EHPM).
Horn's involvement in natural health products dates back to 1977, predating the landmark European recognition of food supplements as part of the food category in 2002. For manufacturers and brand owners operating today, this historical perspective is critical. It underscores the relatively recent formalisation of a sector that was once far less regulated, highlighting the progress made in establishing industry standards and consumer protections.
His tenure as EHPM President from 2017 to 2021, and his current role as Vice President, speaks to his sustained commitment to the industry. EHPM's mission to represent the interests of European manufacturers is vital for ensuring that regulatory frameworks are both robust and practical. From a contract manufacturing standpoint, organisations like EHPM help to shape the environment in which we operate, influencing everything from raw material specifications to labelling requirements. Their advocacy efforts directly impact the ease with which new formulations can be brought to market across different member states.
From Policy Drafting to Private Label Impact
Notably, Horn also contributed to drafting the Belgian plant preparations decree published in 1997. This early engagement in national-level policy demonstrates a pragmatic approach to regulation, acknowledging the specific needs of botanical-based supplements. For private label brands looking to enter or expand within Europe, understanding the nuances of national and EU-wide legislation is paramount, and the historical precedents set in such decrees often inform subsequent broader regulations.
Beyond his advocacy roles, Horn is the owner and a Director on the Board of Ortis Laboratories, a Belgian company. This blend of regulatory influence and direct industry experience offers a comprehensive vantage point. It means the policy decisions he has helped to shape are informed by the real-world challenges faced by manufacturers – from sourcing and formulation to GMP compliance and market access. Such insights are invaluable for ensuring that regulations are not only theoretically sound but also practically implementable by manufacturers like Supplement Factory.
“The blend of regulatory influence and direct industry experience offers a comprehensive vantage point, ensuring policy decisions are informed by real-world challenges faced by manufacturers.”
Horn's ongoing work, including his previous involvement with NAREDI (now BE-SUP), showcases a continuous dedication to building a structured and respected industry. For brand owners considering expansion, aligning with manufacturers who understand and actively engage with these foundational industry bodies can provide a strategic advantage, ensuring products are not only innovative but also compliant across complex European markets.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.